Krystal Biotech, Inc. (KRYS)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Product Revenue, Net	440.48M	389.13M	290.52M
Revenue (Total)	440.48M	389.13M	290.52M

Data Source: Fiscal.ai Last updated: Aug 3, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error